Robert L Kortum
14PUBLICATIONS
79CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Dec 04, 2025
Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer.Hannah E Price, Stacey Stauffer, Hyun Lee
|Nov 25, 2025
SOS1 inhibition suppresses the emergence of osimertinib resistance to generate a durable response in EGFR-mutant lung cancer.Brianna R Daley, Patricia L Theard, Jacob M Hughes
|Sep 16, 2025
Wild-type RAS signaling is an essential therapeutic target in RAS-mutated cancers.Nancy E Sealover, Bridget A Finniff, Jacob M Hughes
|Oct 22, 2024
SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung Adenocarcinoma.Brianna R Daley, Nancy E Sealover, Bridget A Finniff
|Jul 13, 2024
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma.Stacey Stauffer, Jacob S Roth, Edjay R Hernandez
|Dec 18, 2023
SOS1 inhibition enhances the efficacy of and delays resistance to G12C inhibitors in lung adenocarcinoma.Brianna R Daley, Nancy E Sealover, Erin Sheffels
Pageof 3
Frequent Collaborators
5 joint publications
Nancy E Sealover
3 joint publications
Kaja Kostyrko
3 joint publications
Marielle E Yohe
3 joint publications
Elijah F Edmondson
3 joint publications
Erin Sheffels
3 joint publications
Jacob M Hughes
2 joint publications
Simone Difilippantonio
2 joint publications
Matthew D Hall
2 joint publications
Katie E Hebron
2 joint publications
Jacob S Roth
